Treatment of Epiretinal Membranes With Ranibizumab
Status:
Completed
Trial end date:
2012-01-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine whether intraocular injection of ranibizumab
decreases the retinal thickness in patients with epiretinal membranes and reduces associated
symptoms.